Role of pulmonary function tests in the prevention of bleomycin pulmonary toxicity during chemotherapy for metastatic testicular teratoma
- 1 February 1982
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 18 (2) , 133-139
- https://doi.org/10.1016/0277-5379(82)90056-6
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The clinical evaluation of analoguesCancer Chemotherapy and Pharmacology, 1978
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Phase II evaluation of bleomycin.A Southwest Oncology Group studyCancer, 1976
- Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancerCancer, 1976
- Large-Dose Bleomycin Therapy and Pulmonary ToxicityPublished by American Medical Association (AMA) ,1976
- Bleomycin combination chemotherapy in the management of testicular neoplasiaCancer, 1975
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- Bleomycin: Pulmonary ToxicityAnnals of Internal Medicine, 1973
- Bleomycin, an Antitumor AntibioticAnnals of Internal Medicine, 1972
- Study of the Clinical Efficiency of Bleomycin in Human CancerBMJ, 1970